Unlisted imported drugs likely to approve medical insurance reimbursement.

Medical Insurance Price Examination Commission decided to give a chance for unlisted imported drugs to apply the medical insurance reimbursement price approval in 3 months, allowing the drug supplier to clear out the stocks and at the same time considering a continuous supply of such drugs to the medical institutes. This decision will be confirmed at the meeting next week.

In the 3 month pro...